Apolipoprotein E-containing HDL decreases caspase-dependent apoptosis of memory regulatory T lymphocytes.
APOE
CVD
HDL
apolipoproteins
apoptosis
atherosclerosis
lymphocytes
memory Treg
Journal
Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
18
04
2023
revised:
21
07
2023
accepted:
08
08
2023
medline:
23
10
2023
pubmed:
15
8
2023
entrez:
14
8
2023
Statut:
ppublish
Résumé
Plasma levels of HDL cholesterol are inversely associated with CVD progression. It is becoming increasingly clear that HDL plays important roles in immunity that go beyond its traditionally understood roles in lipid transport. We previously reported that HDL interaction with regulatory T cells (Treg) protected them from apoptosis, which could be a mechanism underlying the broad anti-inflammatory effect of HDL. Herein, we extend our work to show that HDL interacts mainly with memory Treg, particularly with the highly suppressive effector memory Treg, by limiting caspase-dependent apoptosis in an Akt-dependent manner. Reconstitution experiments identified the protein component of HDL as the primary driver of the effect, though the most abundant HDL protein, apolipoprotein A-I (APOA1), was inactive. In contrast, APOE-depleted HDL failed to rescue effector memory Treg, suggesting the critical role of APOE proteins. HDL particles reconstituted with APOE, and synthetic phospholipids blunted Treg apoptosis at physiological concentrations. The APOE3 and APOE4 isoforms were the most efficient. Similar results were obtained when lipid-free recombinant APOEs were tested. Binding experiments showed that lipid-free APOE3 bound to memory Treg but not to naive Treg. Overall, our results show that APOE interaction with Treg results in blunted caspase-dependent apoptosis and increased survival. As dysregulation of HDL-APOE levels has been reported in CVD and obesity, our data bring new insight on how this defect may contribute to these diseases.
Identifiants
pubmed: 37579971
pii: S0022-2275(23)00098-6
doi: 10.1016/j.jlr.2023.100425
pmc: PMC10507648
pii:
doi:
Substances chimiques
apolipoprotein E-rich HDL
0
Apolipoprotein E3
0
Apolipoproteins E
0
Apolipoprotein E4
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
100425Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL167200
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL155601
Pays : United States
Organisme : NIDDK NIH HHS
ID : U54 DK126108
Pays : United States
Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.